Author | Alexander Drilon, MD | OncLive

Author | Alexander Drilon, MD

Articles

Dr. Drilon on the Utility of Brigatinib in ALK+ NSCLC

January 31, 2020

Video

Alexander Drilon, MD, discusses the utility of brigatinib in ALK-positive non–small cell lung cancer.

Dr. Drilon on the Utility of Immunotherapy in ALK+ NSCLC

January 24, 2020

Video

Alexander Drilon, MD, discusses the potential utility of immunotherapy in ALK fusion-positive non–small cell lung cancer.

Dr. Drilon on the Safety Profile of Brigatinib in ALK+ NSCLC

January 10, 2020

Video

Alexander Drilon, MD, discusses the safety profile of brigatinib in ALK-positive non­–small cell lung cancer.

Dr. Drilon on Treatment Selection Considerations in ALK+ NSCLC

December 12, 2019

Video

Alexander Drilon, MD, discusses what factors he considers when selecting treatment for patients with ALK fusion-positive non–small cell lung cancer.

x